Profile of Children With Tuberculosis in a Pediatric Intensive Care Unit in Mumbai

Soumya Renji1, Rekha Solomon2, Deepali Wankhade1

  • 1Department of Pediatrics, PD Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra.

Indian Pediatrics
|December 23, 2021
PubMed

Insights

Neurotuberculosis was the primary reason for pediatric intensive care unit admissions. Early diagnosis and drug sensitivity testing are crucial for critically ill children with tuberculosis (TB).

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Mycobacteriology

Background:

  • Tuberculosis (TB) remains a significant global health challenge, particularly in pediatric populations.
  • Critically ill children with TB often present complex clinical scenarios requiring intensive care management.
  • Understanding the profile of pediatric TB patients in intensive care settings is essential for improving outcomes.

Purpose of the Study:

  • To analyze the clinical characteristics and outcomes of confirmed pediatric tuberculosis patients admitted to a pediatric intensive care unit (PICU).
  • To identify the main indications for PICU admission in this patient group.
  • To assess the prevalence of drug resistance among pediatric TB cases in an intensive care setting.

Main Methods:

  • Retrospective analysis of bacteriologically proven pediatric TB cases admitted to a PICU between January 2007 and December 2019.
  • Data collection included patient demographics, reasons for admission, clinical findings, and microbiological results.
  • Drug resistance was classified according to World Health Organization definitions.

Main Results:

  • Fifty-nine children were included, with neurotuberculosis being the most common reason for PICU admission (31 children).
  • Severe respiratory failure and ARDS were observed in some cases.
  • Drug sensitivity testing revealed significant rates of multidrug-resistant, pre-extreme drug-resistant, and extreme drug-resistant tuberculosis.

Conclusions:

  • Neurotuberculosis is a leading cause of PICU admission for pediatric TB patients.
  • Emphasis should be placed on obtaining microbiological samples for culture and drug sensitivity testing in critically ill children with suspected or confirmed TB.
  • Improved diagnostic strategies are needed for early detection and management of drug-resistant TB in children.
Abstract

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
389
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
263
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
225
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
611
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
503
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
520